Liposomal delivery of vitamin E based compounds

Details for Australian Patent Application No. 2002361812 (hide)

Owner Research Development Foundation

Inventors Knight, J Vernon; Sanders, Bob G; Menchaca, Marla S; Wellen, Clyde W; Kline, Kimberly; Lawson, Karla A

Agent Callinan

Pub. Number AU-B-2002361812

PCT Number PCT/US02/40846

PCT Pub. Number WO2003/053407

Priority 60/418,602 15.10.02 US; 60/406,807 29.08.02 US; 60/342,156 19.12.01 US

Filing date 19 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 8 November 2007

International Classifications

C07D 311/72 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/355 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4745 (2006.01)

A61K 31/704 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 60/418,602 15.10.02 US; 60/406,807 29.08.02 US; 60/342,156 19.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002361812

8 November 2007 Application Accepted

  Published as AU-B-2002361812

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361813-COMPOSITIONS AND METHODS RELATING TO HEPATIC SPECIFIC GENES AND PROTEINS

2002361811-1,3-BIS-(SUBSTITUTED-PHENYL)-2-P ROPYN-1-ONES AND THEIR USE TO TREAT DISORDERS